Cytospire Therapeutics

News

Cytospire was in the spotlight this morning after announcing an oversubscribed Series A to fund a new form of T-cell engager (TCE) for cancer.

News

Electra Therapeutics has moved ahead with plans for an IPO, seeking to raise funds for its drug for the rare and life-threatening disease sHLH.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.